The IV Equipment Market is positioned for continued expansion as hospitals and healthcare facilities face increasing demand for intravenous therapies across oncology, cardiology, neurology, gastroenterology, and other medical applications. The market was valued at USD 24.12 billion in 2024 and is projected to grow from USD 24.88 billion in 2025 to USD 34.0 billion by 2035, registering a CAGR of 3.17%.

Oncology is the leading application segment, representing approximately 34.6% of the market. Intravenous administration is widely used for cancer medications and supportive therapies, making dependable IV equipment essential for oncology departments. The continuing global demand for cancer treatment is therefore supporting the adoption of catheters, infusion pumps, IV sets, and related accessories.

Hospitals represent the largest end-user segment, holding approximately 67.2% market share in 2024. Hospitals use IV equipment across multiple departments, including emergency care, surgery, intensive care, oncology, and general inpatient treatment. Increasing admissions and the aging population are contributing to sustained equipment requirements.

The product landscape is led by IV catheters, which account for approximately 58.4% of the market. Catheters are essential for establishing intravenous access and are used across a broad range of medical procedures. IV infusion pumps are also becoming increasingly important as hospitals seek greater control over medication and fluid administration.

Technological development is creating additional growth opportunities. Smart infusion pumps, connected devices, automated medication delivery systems, and improved monitoring capabilities can support safer and more efficient intravenous treatment. The integration of IV equipment with digital healthcare platforms may further improve clinical workflows.

North America led the global market in 2024 with more than 40.22% share and approximately USD 9.7 billion in revenue. Europe followed with a 24.88% share and a market value of USD 6.0 billion. Asia-Pacific is also gaining importance as healthcare access, urbanization, and medical infrastructure continue to improve.

Looking toward 2035, the IV Equipment Market is expected to benefit from rising chronic disease prevalence, expanding healthcare infrastructure, home-based treatment, and technological innovation. Manufacturers that focus on patient safety, connectivity, portability, and regulatory compliance are likely to remain well positioned in the evolving intravenous therapy landscape.